Filter articles using the following links

39th Annual J.P. Morgan Healthcare Conference – Virtual

GenSight Biologics announces the partial conversion of convertible bonds and full exercise of share warrants by Kreos Capital

GenSight Biologics Announces Publication of Results from LUMEVOQ® REVERSE Pivotal Phase III Trial and Non-Human Primate Study in Science Translational Medicine

Article – EN

Bryan Garnier European Healthcare Conference 2020 – virtual event

American Academy of Ophthalmology 2020 – Virtual

GenSight Biologics reports validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency

Eyecelerator 2020 – Virtual Conference

World Orphan Drug Congress Europe 2020 – Live Digital

GenSight Biologics successfully raises €25 million in an oversubscribed private placement with US and European institutional investors